Baker, Donelson, Bearman, Caldwell & Berkowitz, PC, recently launched a Drug, Device & Life Sciences Industry Service Team, combining resources from its nationally recognized health law, business, intellectual property and product liability practices to address the increasing multidisciplinary needs of pharmaceutical, medical device and life sciences clients.
"Changes such as recent and pending court decisions, evolving litigation climates, and of course, the economy, present significant challenges to our clients that we are well prepared to address. We created this group to help medical device companies, medical equipment and supply companies, pharmaceutical companies and bioscience companies confront these problems comprehensively," said J. Carter Thompson, Jr., co-chair of the Drug, Device & Life Sciences team.
With more than 80 members firm-wide, the Drug, Device & Life Sciences team is one of the country's largest such groups and is uniquely positioned to provide a comprehensive range of capabilities. The group's attorneys and advisors provide counsel in the changing legislative, regulatory and economic environment and advise on strategies for successful interaction with federal regulatory agencies such as Health and Human Services (HHS), Centers for Medicare and Medicaid Services (CMS), Food and Drug Administration (FDA), Federal Trade Commission (FTC), Patent and Trademark Office (PTO) and Drug Enforcement Administration (DEA). In addition, the team members' experience extends to traditional areas including finance, mergers and acquisitions, business structures and planning, tax, real estate, labor and employment, governmental compliance, intellectual property, customs, government investigations, product liability issues and litigation matters.
For more information about the Industry Service Team, please contact J. Carter Thompson, Jr.